Citation

Jones M, Gray R. J. Psychiatr. Ment. Health Nurs. 2008; 15(3): 253-259.

Affiliation

Surrey and Borders Partnership NHS Trust, The Ridgewood Centre, Frimley, UK.

Copyright

(Copyright © 2008, John Wiley and Sons)

DOI

10.1111/j.1365-2850.2007.01189.x

PMID

18307655

Abstract

This paper explores the theoretical risks associated with the increase of suicide in people with schizophrenia treated with partial agonists (dopamine system stabilizers). The paper discusses what we think may be happening in the brains of people with schizophrenia which contributes to their difficulties, how antipsychotic medication can ease these difficulties, and the pharmacological theory as to why an increased risk of suicide may occur with the use of partial agonists. Finally, the core nursing interventions to minimize the potential risks of suicide when caring for people who are prescribed partial agonists are described.

Language: en